Merck Highlights Its Commitment to Infectious Disease with 40 Presentations of Data at ICAAC/ICC 2015
Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today announced that more than 40 presentations of data on a number of
Merck’s investigational and established infectious disease products are
scheduled for the upcoming Interscience Conference of Antimicrobial
Agents and Chemotherapy (ICAAC) and International Congress of
Chemotherapy and Infection (ICC) joint meeting in San Diego, Sept. 17-21.
Language:
English
Contact:
MerckMedia:Doris Li, 908-246-5701orIan McConnell, 973-901-5722orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more
Source: Merck.com - Product News - Category: Drugs & Pharmacology Tags: Prescription Medicine News Research and Development News Corporate News Latest News Source Type: news
More News: Chemotherapy | Conferences | Drugs & Pharmacology | Infectious Diseases | Merck | Politics